Skip to main content

8110 Gatehouse Road, Falls Church, VA 22042

Improving the approach to and management of the older patient with metastatic gastric cancer (Fox Chase MGC)


General Information

Age Group

Adults ages 40 and older



Protocol Number


Background Information

The purpose of this research study is to enhance the care of the older patient with mGC/mEC/mGEJC. The study will evaluate the benefit of incorporating geriatric assessments into the routine care of patients.

Offered At

Inova Schar Cancer Institute
8081 Innovation Park Drive
Fairfax, VA 22031
A department of Inova Fairfax Hospital

Eligibility Information

  • Adults age 70 and older
  • Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation
  • Evidence of metastatic gastric cancer (mGC), metastatic esophageal cancer (mEC), or metastatic gastroesophageal junction cancer (mGEJC). Patients can be enrolled at any stage of their treatment or disease course
  • Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy
  • Life expectancy ≥3 months
  • Additional eligibility in protocol

Ineligibility Information

  • ≤69 years old (participants may be eligible at a later date)
  • Inability to read and understand English
  • No evidence of mGC (participants may be eligible if evidence of mGC occurs)
  • Not on active therapy
  • Life expectancy <3 months
  • Additional ineligibility in protocol

Additional information can be found at: